Cingulate Inc (CING)
0.701
-0.02
(-2.26%)
USD |
NASDAQ |
May 31, 16:00
0.7001
0.00 (0.00%)
After-Hours: 20:00
Cingulate Price to Book Value: 1.318 for May 31, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 1.318 |
| May 30, 2024 | 1.348 |
| May 29, 2024 | 1.316 |
| May 28, 2024 | 1.330 |
| May 24, 2024 | 1.483 |
| May 23, 2024 | 1.551 |
| May 22, 2024 | 1.514 |
| May 21, 2024 | 1.560 |
| May 20, 2024 | 1.485 |
| May 17, 2024 | 1.508 |
| May 16, 2024 | 1.485 |
| May 15, 2024 | 1.485 |
| May 14, 2024 | 1.523 |
| May 13, 2024 | 1.487 |
| May 10, 2024 | 1.431 |
| May 09, 2024 | 1.664 |
| May 08, 2024 | 1.670 |
| May 07, 2024 | 1.667 |
| May 06, 2024 | 1.637 |
| May 03, 2024 | 1.814 |
| May 02, 2024 | 2.106 |
| May 01, 2024 | 1.955 |
| April 30, 2024 | 1.724 |
| April 29, 2024 | 1.643 |
| April 26, 2024 | 1.655 |
| Date | Value |
|---|---|
| April 25, 2024 | 1.579 |
| April 24, 2024 | 1.636 |
| April 23, 2024 | 1.652 |
| April 22, 2024 | 1.666 |
| April 19, 2024 | 1.653 |
| April 18, 2024 | 1.654 |
| April 17, 2024 | 1.601 |
| April 16, 2024 | 1.523 |
| April 15, 2024 | 1.466 |
| April 12, 2024 | 1.732 |
| April 11, 2024 | 1.498 |
| April 10, 2024 | 1.559 |
| April 09, 2024 | 1.574 |
| April 08, 2024 | 1.574 |
| April 05, 2024 | 1.605 |
| April 04, 2024 | 1.667 |
| April 03, 2024 | 1.667 |
| April 02, 2024 | 1.667 |
| April 01, 2024 | 1.698 |
| March 28, 2024 | |
| March 27, 2024 | |
| March 26, 2024 | |
| March 25, 2024 | |
| March 22, 2024 | |
| March 21, 2024 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6294
Minimum
Mar 08 2022
160.26
Maximum
May 01 2023
21.87
Average
1.448
Median
Jul 14 2022
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 18.40 |
| iBio Inc | 0.8255 |
| Theriva Biologics Inc | 0.1377 |
| Oragenics Inc | 8.766 |
Price to Book Value Related Metrics
| Price | 0.701 |
| Earnings Yield | -3.42K% |
| Market Cap | 4.239M |